Product Information
EMEND 80 MG CAPSULE is a brand product labeled by Merck Sharp & Dohme LLC, priced at $208.9830 per EA under NDC 00006046102. Its NADAC has been published 330 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the aprepitant market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
80 mg/1
Manufacturer
Merck Sharp & Dohme LLCNDC
00006046102
Classification
Brand
Dosage Form
CAPSULE
Route
ORAL
Last Updated
1/22/2025
Active Ingredients
APREPITANTApproval Type
New Drug (NDA)
FDA Application
NDA021549On Market Since
3/26/2003
Pharmacological Classes
Price Statistics
The NADAC for EMEND 80 MG CAPSULE has been published 330 times since Nov 28, 2013, and over the history we have for it it has risen 89.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $208.9830 per EA |
|---|---|
| All-time high | $210.6048 (Jan 16, 2019) |
| All-time low | $110.0237 (Nov 28, 2013) |
| 52-week high | $208.9830 |
| 52-week low | $208.9830 |
| Median price | $191.6465 |
| Average price | $172.5423 |
| Largest weekly change | +9.9% (Jan 18, 2017) |
| Weeks tracked | 330 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 67% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EMEND 80 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for EMEND 80 MG CAPSULE, manufactured by Merck Sharp & Dohme LLC, is $208.9830 per EA (NDC 00006046102), effective Jan 14, 2026.
How has the price of EMEND 80 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for EMEND 80 MG CAPSULE has risen 89.9%. It has been tracked across 330 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EMEND 80 MG CAPSULE?
Since Nov 28, 2013, the NADAC for EMEND 80 MG CAPSULE has ranged from a low of $110.0237 (Nov 28, 2013) to a high of $210.6048 (Jan 16, 2019), with a median of $191.6465 per EA.
Are there cheaper alternatives to EMEND 80 MG CAPSULE?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, APREPITANT 80 MG CAPSULE, is $69.0312 per EA — about 67% below EMEND 80 MG CAPSULE.
Who manufactures EMEND 80 MG CAPSULE?
EMEND 80 MG CAPSULE (NDC 00006046102) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification